Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
A Friend in Need May Not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases.
Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
[Treatment of relapses of multiple sclerosis (a review)].
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Advances in the management of MS symptoms: real-life evidence.
Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection.
Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients.
A wireless body measurement system to study fatigue in multiple sclerosis.
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
Missing links in multiple sclerosis etiology. A working connecting hypothesis.
Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β
Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis.
In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis.
What do healthcare providers advise women with multiple sclerosis regarding pregnancy?
Accuracy of a custom physical activity and knee angle measurement sensor system for patients with neuromuscular disorders and gait abnormalities.
Contextualized perceptions of movement as a source of expanded insight: People with multiple sclerosis' experience with physiotherapy.
Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis.
FRACTALKINE GENE RECEPTOR POLYMORPHISM IN PATIENTS WITH MULTIPLE SCLEROSIS.
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?
Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis.
Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors.
Neuroprotective effects of chrysin: From chemistry to medicine.
Future treatment approaches to multiple sclerosis.
Pages
« first
‹ previous
…
331
332
333
334
335
336
337
338
339
…
next ›
last »